Keratinocyte Carcinoma

• Keratinocyte Carcinoma is the most prevalent type of skin cancer, primarily linked to UV exposure.
• It encompasses Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC).
• Symptoms often include new growths, sores that don’t heal, or changing skin lesions.
• Early detection is vital for successful treatment.
• Treatment options range from surgical removal to radiation and topical therapies.

What is Keratinocyte Carcinoma?

Keratinocyte Carcinoma refers to a group of skin cancers that develop from keratinocytes, the most abundant cells in the epidermis. These cells are responsible for producing keratin, a protective protein. This type of cancer is the most common form of malignancy globally, with its incidence steadily rising, particularly among fair-skinned populations. According to the World Health Organization (WHO), non-melanoma skin cancers, which include keratinocyte carcinomas, account for at least 2 to 3 million new cases each year worldwide. Chronic exposure to ultraviolet (UV) radiation from sunlight or tanning beds is the primary risk factor for its development.

Keratinocyte Carcinoma: Symptoms and Types

Recognizing keratinocyte carcinoma symptoms is key to early diagnosis. These symptoms often manifest as changes on the skin, particularly in sun-exposed areas. Common signs include:

• A new growth or sore that does not heal within a few weeks.
• A pearly or waxy bump, often with visible blood vessels (common for BCC).
• A flat, flesh-colored or brown scar-like lesion (also common for BCC).
• A firm, red nodule (common for SCC).
• A flat lesion with a scaly, crusted surface (common for SCC).

There are two main types of keratinocyte carcinoma: Basal Cell Carcinoma (BCC) and Squamous Cell Carcinoma (SCC). Basal Cell Carcinoma is the most frequent type, accounting for about 80% of all non-melanoma skin cancers. It typically grows slowly and rarely spreads to other parts of the body. Squamous Cell Carcinoma is the second most common type, making up about 20% of cases. While still highly treatable, SCC has a higher risk of spreading if not detected and treated early. Both types are strongly associated with cumulative UV exposure.

Keratinocyte Carcinoma Treatment Options

The choice of keratinocyte carcinoma treatment depends on several factors, including the type and size of the cancer, its location, and the patient’s overall health. Early detection generally leads to simpler and more effective treatments. Surgical removal is the most common approach. This can involve:

• Surgical Excision: The tumor and a small margin of healthy tissue are cut out.
• Mohs Micrographic Surgery: A precise technique where thin layers of cancer-containing skin are progressively removed and examined until only cancer-free tissue remains. This method is often used for cancers on the face or other cosmetically sensitive areas, or for larger, recurrent tumors.
• Curettage and Electrodesiccation: The cancerous tissue is scraped away, and the base is burned with an electric needle.

Non-surgical options may also be considered, especially for superficial or low-risk lesions, or for patients who are not candidates for surgery. These include radiation therapy, cryotherapy (freezing the cancer cells), photodynamic therapy (using light and a drug to kill cancer cells), and topical medications such as imiquimod cream or 5-fluorouracil cream. Regular follow-up appointments are essential after treatment to monitor for recurrence or the development of new lesions.